Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.

Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma. Expert Opin Investig Drugs. 2010 May; 19(5):663-72.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.